Company: RGNT
Filing Date: 2025-01-24
Form Type: DRS
Source: 0001213900-25-006245
Chunk: 307

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-24
Form: DRS
Chunk 307
---
, and Teva Medical (Marketing) Ltd., dated January 6, 2009                                                                         |
| 10.4*   |     | Services Agreement, by and between Regentis Biomaterials Ltd. and Baxter Healthcare Corporation, dated February 27, 2018                                                                                                                        |
| 10.5*   |     | Agreement, by and between Regentis Biomaterials Ltd. and Shimony Yosef Certified Public Accountant (Isr.), dated ‌December 5, 2022                                                                                                              |
| 10.6*   |     | Data Agreement, by and between Regentis Biomaterials Ltd and TiGenix NV, dated July 20, 2015.                                                                                                                                                   |
| 10.7*   |     | Series B Preferred Share Purchase Agreement, by and between Regentis Biomaterials Ltd., The Technological Incubator Founded by the Technion R&D Foundation Ltd., Dr. Dror Seliktar, Mr. Yehiel Tal and certain investors, dated August 2, 2007. |
| 10.8*   |     | Bridge Loan Agreement dated October 15, 2024 by and among Regentis Biomaterials Ltd. and the lender parties thereto                                                                                                                             |
| 10.9*   |     | Amendment and Addendum dated November 12, 2024 to the Loan Agreement by and among Regentis Biomaterials Ltd. and the lender parties thereto                                                                                                     |
| 10.10*  |     | Convertible Loan Agreement dated March 29, 2020, by and among Regentis Biomaterials Ltd. and the lender parties thereto                                                                                                                         |
| 10.11*  |     | Amendment and Addendum dated October 15, 2024 to the 2020 Convertible Loan Agreement by and among Regentis Biomaterials Ltd. and the lender parties thereto                                                                                     |

<div align='center'>II-7</div>

| 10.12* 
 10.13* |     | Loan Agreement dated December 20, 2023, by and among Regentis Biomaterials Ltd. and the lender parties thereto                                    
 Amendment and Addendum dated November 19, 2024, to the 2023 Loan Agreement by and among Regentis Biomaterials Ltd. and the lender parties thereto |
|:-------|:----|:--------------------------------------------------------------------------------------------------------------------------------------------------|
| 23